作者:Stephanie Wohnig、Anatol P. Spork、Stefan Koppermann、Gottfried Mieskes、Nicolas Gisch、Reinhard Jahn、Christian Ducho
DOI:10.1002/chem.201604279
日期:2016.12.5
membrane protein translocase I (MraY) is a key enzyme in bacterial peptidoglycan biosynthesis. It is therefore frequently discussed as a target for the development of novel antibiotics. The screening of compound libraries for the identification of MraY inhibitors is enabled by an established fluorescence‐based MraY assay. However, this assay requires a dansylated derivative of the bacterial biosynthetic
膜蛋白转位酶I(MraY)是细菌肽聚糖生物合成中的关键酶。因此,经常将其作为开发新型抗生素的靶标进行讨论。通过已建立的基于荧光的MraY分析,可以筛选用于鉴定MraY抑制剂的化合物库。然而,该测定需要细菌生物合成中间体Park的核苷酸的丹磺酰化衍生物作为MraY底物。从细菌中分离出Park的核苷酸并随后进行丹磺酰化只能提供有限量的这种底物,从而妨碍了高通量筛选MraY抑制剂。因此,在提供这种有希望的药物靶标时,有效提供丹磺酰化的Park核苷酸是一个主要的瓶颈。在这项工作中,